1. 2020
  2. Identifying the variables that drive tamoxifen-independent CreERT2 recombination: implications for microglial fate mapping and gene deletions.

    Van Hove, H., Pombo Antunes, A. R., De Vlaminck, K., Scheyltjens, I., Van Ginderachter, J. & Movahedi, K., 3 Mar 2020, In : European Journal of Immunology. 50, 3, p. 459-463 5 p.

    Research output: Contribution to journalArticle

  3. 2019
  4. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment

    Van Hove, H., Martens, L., Scheyltjens, I., De Vlaminck, K., Pombo Antunes, A. R., De Prijck, S., Vandamme, N., De Schepper, S., Van Isterdael, G., Scott, C. L., Aerts, J., Berx, G., Boeckxstaens, G. E., Vandenbroucke, R. E., Vereecke, L., Moechars, D., Guilliams, M., Van Ginderachter, J., Saeys, Y. & Movahedi, K., 6 May 2019, In : Nature Neuroscience. 22, 6, p. 1021-1035 15 p.

    Research output: Contribution to journalArticle

  5. 2018
  6. RoMo: An efficient strategy for functional mosaic analysis via stochastic Cre recombination and gene targeting in the ROSA26 locus

    Movahedi, K., Wiegmann, R., De Vlaminck, K., Van Ginderachter, J. A. & Nikolaev, V. O., Jul 2018, In : Biotechnology and Bioengineering. 115, 7, p. 1778-1792 15 p.

    Research output: Contribution to journalArticle

ID: 11825469